Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 3Malignant Ascites 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Refractory Malignant Ascites 1Prostatic Neoplasms 1Ovarian High Grade Serous Adenocarcinoma 1Multiple Myeloma 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast) 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Paracentesis 1Biopsy 1Atovaquone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian High Grade Serous Adenocarcinoma × Paracentesis × Clear all
NCT05998135 2025-09-11

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Emory University

Phase 2 Recruiting
28 enrolled
Gynecologic

Ovarian High Grade Serous Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡